Vaxart COVID-19 vaccine

Vaxart COVID-19 vaccine

Vaccine description
Target	SARS-CoV-2
Vaccine type	Viral vector
Clinical data
Other names	VXA-CoV2-1, VXA-CoV2-1.1-S
Routes of administration	Oral
Identifiers
CAS Number	2543668-36-4[1]

Vaxart COVID-19 vaccine is a COVID-19 vaccine candidate developed by Vaxart.^[2][3][4]

References

1. "Patent Landscape Report COVID-19-related vaccines and therapeutics" (PDF).
2. Clinical trial number NCT04563702 for "Safety and Immunogenicity Trial of an Oral SARS-CoV-2 Vaccine (VXA-CoV2-1) for Prevention of COVID-19 in Healthy Adults" at ClinicalTrials.gov
3. Clinical trial number NCT05067933 for "Ph 1b: Safety & Immunogenicity of Ad5 Based Oral Norovirus Vaccine (VXA-NVV-104)" at ClinicalTrials.gov
4. Clinical trial number NCT05067933 for "A Ph 2 Trial With an Oral Tableted COVID-19 Vaccine" at ClinicalTrials.gov